Co-Authors
This is a "connection" page, showing publications co-authored by Natalija Novak and Beatriz Cabanillas.
Connection Strength
5.924
-
Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia. Int Rev Immunol. 2021 Jul 12; 1-10.
Score: 0.956
-
COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?" Allergy. 2021 06; 76(6):1938-1940.
Score: 0.948
-
COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: "Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines". Allergy. 2021 06; 76(6):1943-1944.
Score: 0.948
-
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol? Allergy. 2021 06; 76(6):1617-1618.
Score: 0.948
-
Allergy to COVID-19 vaccines: A current update. Allergol Int. 2021 Jul; 70(3):313-318.
Score: 0.941
-
Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS-CoV-2. Immunology. 2020 10; 161(2):83-93.
Score: 0.898
-
SARS-CoV-2, COVID-19, skin and immunology - What do we know so far? Allergy. 2021 03; 76(3):698-713.
Score: 0.224
-
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation. Allergy. 2021 11; 76(11):3307-3313.
Score: 0.059